SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.44+1.5%2:02 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (3025)5/29/1998 7:55:00 AM
From: Chris M.  Read Replies (3) of 9523
 
Great news in today's Washington Post:

"A senior FDA official noted that only four of the deaths described in
the reports clearly occurred after individuals took the drug. That
number is too small to draw any conclusions, especially because
about 1 million prescriptions for the drug have been filled since it
went on the market, the official said.

"This does not seem to represent a trend or a signal or something
worrisome to us at this point," said the official, who asked not to
be identified. The official added, however, that the agency expects
to receive more reports over time -- in part because of news
media attention to the drug. "We will continue our ongoing
monitoring" to "see if something begins to say there is a signal
here. Based on what we've got here, we're not at that point," the
official said."

In London trading:

Drug group Pfizer (PFE - news) was quoted up $3/8 at $107 after the company said it had reviewed the
circumstances surrounding the deaths of six people taking its impotence drug Viagra, and decided not to make any
changes to the drug's labelling.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext